SShortSingh.
Back to feed

Uber Lobbies to Slow Autonomous Vehicle Adoption, Citing Monopoly Concerns

0
·1 views

Uber has actively pushed policy measures in at least two jurisdictions that could hinder the growth of self-driving vehicle technology. The ride-hailing giant claims its lobbying efforts are aimed at preventing monopolistic control of the autonomous vehicle market. Critics, however, suggest the strategy may be designed to protect Uber's own competitive position against self-driving car developers. The moves highlight the growing tension between traditional ride-hailing platforms and emerging autonomous vehicle companies.

Read the full story at WIRED

This is an AI-generated summary. ShortSingh links to the original source for the complete article.

Discussion (0)

Log in to join the discussion and vote.

Log in

Related stories

0
ScienceWIRED ·

Best Robotic Pool Cleaners of 2026: Top Picks Reviewed

Robotic pool cleaners are emerging as a practical alternative to hiring professional pool maintenance services. Leading models from brands such as Beatbot, iGarden, and Dreame have been highlighted as top performers in 2026. These automated devices are designed to independently maintain water quality in residential pools. Their growing popularity reflects increasing consumer interest in smart home automation for outdoor spaces.

0
ScienceWIRED ·

Apple Announces New Child Safety Features Coming to iOS 27

Apple has announced a set of new child safety features set to arrive with iOS 27 on iPhones and other Apple devices. The updates are designed to better protect younger users across the company's ecosystem. While Apple has confirmed the changes are coming, specific details about the full scope of the features have not yet been disclosed. The announcement signals Apple's continued focus on improving safeguards for children on its platforms.

0
ScienceWIRED ·

Scientists Use AI and Quantum Computing to Discover New Peptide Drug Candidates

A group of researchers has demonstrated how quantum computing combined with AI can be used to generate new peptides with potential therapeutic applications. The work was carried out with limited funding and time, reflecting a grassroots scientific effort rather than a well-resourced institutional project. The study focused on addressing medical needs of underserved populations and finding treatments for rare diseases. By leveraging quantum computing, the team aimed to accelerate and improve the drug discovery process beyond what classical computing methods allow.